< 1 MIN READ | Wellness

New Research Explores Life Expectancy and Healthcare Costs for Patients with Rheumatoid Arthritis

Cite This
, (2020, December 9). New Research Explores Life Expectancy and Healthcare Costs for Patients with Rheumatoid Arthritis. Psychreg on Wellness. https://www.psychreg.org/life-expectancy-arthritis-pain/
Reading Time: < 1 minute

A new study published in Arthritis & Rheumatology suggests that recent advances in the treatment of rheumatoid arthritis have prolonged patients’ lives but also increased healthcare costs.

For the study, investigators examined medical claims data from the National Health Insurance of Taiwan, identifying 29,352 new cases of rheumatoid arthritis from 2003-2016.

The life expectancy after rheumatoid arthritis diagnosis was 26.3 years, and the lifetime cost was estimated to be US $72,953 after disease-modifying antirheumatic drugs called biologics became available in 2003.

‘After the availability of biologics, rheumatoid arthritis patients appeared to live longer with higher lifetime expenditures that should be monitored and evaluated for cost-effectiveness,’ the authors wrote.


Disclaimer: Psychreg is mainly for information purposes only. Materials on this website are not intended to be a substitute for professional advice, diagnosis, medical treatment, or therapy. Never disregard professional psychological or medical advice nor delay in seeking professional advice or treatment because of something you have read on this website. Read our full disclaimer here

Copy link